Associated tags: Research, Robotics, Other Science, Opentrons, Science, Genomics, Health, NGS, Proteomics, Biotechnology
Locations: NEW YORK, UNITED STATES, NORTH AMERICA, MASSACHUSETTS, US, AETNA, SAVOY
University,
Biotechnology,
Primary,
Secondary,
Education,
Technology,
Health,
Robotics,
Other Science,
Research,
Science,
Hardware,
Automation,
Virginia Tech,
Assistant,
Data analysis,
MIT,
Research design,
University College London,
Student,
Ecosystem,
Colorado State University,
J. Craig Venter Institute,
Carnegie Mellon University,
Teaching,
Associate professor Opentrons Labworks, Inc ., a leader in lab automation and makers of accessible lab robotics, today announced the launch of Opentrons® for Education, an exclusive offering for educators to bring lab automation to the classroom.
Key Points:
- Opentrons Labworks, Inc ., a leader in lab automation and makers of accessible lab robotics, today announced the launch of Opentrons® for Education, an exclusive offering for educators to bring lab automation to the classroom.
- Opentrons is building a first-of-its-kind ecosystem for teaching with automation, which includes education pricing and support, along with access to a community of educators already teaching with Opentrons.
- Opentrons for Education is the key to unlocking a new era of hands-on, innovative learning in the realm of laboratory sciences.
- in Automated Science Program, Computational Biology Department at Carnegie Mellon University, said, “This initiative underscores Opentrons' commitment to shaping the future of laboratory automation education for aspiring scientists.
Retrieved on:
Thursday, February 22, 2024
Robotics,
Technology,
Other Science,
Research,
Artificial Intelligence,
Science,
Hardware,
Doctor of Philosophy,
Multimedia,
Cole,
History,
Worcester Polytechnic Institute,
IP,
3D printing Opentrons Labworks, Inc. , a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer.
Key Points:
- Opentrons Labworks, Inc. , a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer.
- View the full release here: https://www.businesswire.com/news/home/20240222831212/en/
"Greg's remarkable experience underscores his proficiency in steering robotic technologies towards successful commercialization," said Jonathan Brennan-Badal, CEO of Opentrons.
- Dr. Cole served as Chief Technology Officer and Advisor at AiM Medical Robotics, responsible for developing and manufacturing image-guided robotic surgical devices and R&D platforms.
- I’m looking forward to bringing my expertise in engineering to help them advance Opentrons Flex and other automated solutions," said Dr. Cole.
Retrieved on:
Thursday, February 1, 2024
Data Management,
Technology,
Health,
Robotics,
Other Science,
Medical Devices,
Research,
Software,
Artificial Intelligence,
Genetics,
Science,
Cell biology,
Ecosystem,
Database,
Exhibition,
Disease,
Genomics,
Proteomics,
Convention center,
SLAS,
Carnegie Mellon University,
MIT,
Genome,
Conference,
Synthetic biology,
Consumer electronics Opentrons Labworks, Inc ., a leader in lab automation and makers of accessible lab robotics, today announced the launch of its new protocol library, offering plug-and-play protocols for all Opentrons robots, including the Opentrons Flex™.
Key Points:
- Opentrons Labworks, Inc ., a leader in lab automation and makers of accessible lab robotics, today announced the launch of its new protocol library, offering plug-and-play protocols for all Opentrons robots, including the Opentrons Flex™.
- Opentrons is building a first-of-its-kind ecosystem for simplifying and scaling lab automation, which comprises the protocol library along with generative AI tools for protocol development, coupled with stringent wet- and dry-lab verification processes.
- The aim is to create the largest open-access set of robust liquid-handling automation protocols to streamline research across genomics, proteomics, cell biology, and synthetic biology.
- “With hundreds of protocols already developed by our community of users and internal scientific team, the easily accessible protocol library and our latest innovation in generative-AI protocol development tools both mark a major milestone for scientists.
Retrieved on:
Tuesday, January 30, 2024
Robotics,
Data Management,
Technology,
Other Science,
Software,
Research,
Science,
Incubator,
Data management,
Therapy,
Drug discovery,
Genomics,
Proteomics,
OT-2,
E-commerce Opentrons Labworks, Inc ., a leader in lab automation and makers of accessible lab robotics, today announced the launch of its automation marketplace, with tools and software from Opentrons’ partners that can be easily integrated into Opentrons robotics systems, catering to rapidly expanding sectors like drug discovery and microbiome research.
Key Points:
- Opentrons Labworks, Inc ., a leader in lab automation and makers of accessible lab robotics, today announced the launch of its automation marketplace, with tools and software from Opentrons’ partners that can be easily integrated into Opentrons robotics systems, catering to rapidly expanding sectors like drug discovery and microbiome research.
- The first marketplace partners include research platform and technology companies Cerillo , Genie Life Sciences , and Byonoy .
- Genie Life Sciences has developed new lab execution software known as Genie LabOS, a user-friendly platform built for simplifying lab automation workflows.
- To learn more about Opentrons automation marketplace, please visit https://opentrons.com/automation-marketplace/
DNA,
Partnership,
Methylation,
Nucleic acid thermodynamics,
Workflow,
NGS,
DNA sequencing,
Liquid biopsy,
Business,
Research,
Collection,
Robotics,
Fluid mechanics,
Automation,
Fine chemical,
Vaccine,
Opentrons IRVINE, Calif., July 24, 2023 /PRNewswire/ -- Zymo Research Corp, a leading provider of life science technologies, has partnered with Opentrons Labworks, Inc., a leader in lab automation, to revolutionize cell-free DNA isolation and analysis. The collaboration brings an innovative fully automated, comprehensive workflow from sample collection through library preparation transforming liquid biopsy analysis.
Key Points:
- IRVINE, Calif., July 24, 2023 /PRNewswire/ -- Zymo Research Corp , a leading provider of life science technologies, has partnered with Opentrons Labworks, Inc., a leader in lab automation, to revolutionize cell-free DNA isolation and analysis.
- Current, common methods of liquid biopsy extraction can be challenging for cancer research due to inefficient recovery of cell-free DNA.
- The Zymo Research and Opentrons partnership offers a new approach that overcomes the hurdles of these common methods.
- Zymo Research will be at booth #3089 and Opentrons will be at booth #1978.
Retrieved on:
Wednesday, April 12, 2023
NGS,
Microfluidics,
Growth,
Knowledge,
PerkinElmer,
Laboratory,
Research,
Atwood,
Genomics,
Management,
Opentrons BROOKLYN, N.Y., April 12, 2023 /PRNewswire/ -- Opentrons Labworks, Inc., a life sciences company at the forefront of the Laboratory 4.0 movement, today announced the appointment of James Atwood as General Manager of its Opentrons Robotics Business Unit. With Atwood's expertise in genomics and laboratory research tool development, the company is in a strong position as it expands commercialization of its OT-2 liquid-handling robot and prepares for the next generation of advanced lab automation robots.
Key Points:
- As General Manager, Atwood will leverage experience in sales and product management within the life science sector to solidify Opentrons' position as a leader in laboratory automation.
- BROOKLYN, N.Y., April 12, 2023 /PRNewswire/ -- Opentrons Labworks, Inc ., a life sciences company at the forefront of the Laboratory 4.0 movement, today announced the appointment of James Atwood as General Manager of its Opentrons Robotics Business Unit.
- "We are excited to welcome James during this exciting period of growth," said Jonathan Brennan-Badal, CEO of Opentrons.
- Before joining Opentrons, Atwood was vice president of the omics business division of genomics tool company MOBILion Systems.
Research,
Infectious Diseases,
FDA,
Other Health,
Family,
Biotechnology,
Consumer,
Health,
Science,
Other Science,
Food and Drug Administration,
List of life sciences,
CVS Health,
Acquisition,
FDA,
PRL,
COVID-19,
Compliance,
Medical tourism,
Health,
Food,
Leadership,
Research,
CEO,
Growth,
Robotics,
Boratto,
Merck,
Synthetic biology,
UPS,
Industry,
Biotechnology,
COVID-19 testing,
Management,
Pharmaceutical industry,
Opentrons Opentrons Labworks, Inc., today announced the appointments of Eva Boratto as chief financial officer and member of the board of directors, and Veleka Peeples-Dyer as chief legal and compliance officer.
Key Points:
- Opentrons Labworks, Inc., today announced the appointments of Eva Boratto as chief financial officer and member of the board of directors, and Veleka Peeples-Dyer as chief legal and compliance officer.
- Boratto joins Opentrons following her role as executive vice president and chief financial officer of CVS Health, Inc., a Fortune 5 company.
- She brings more than 30 years of healthcare experience as a financial executive with a focus on organic and inorganic growth, financial performance, insightful analytics, and increased accountability and transparency.
- Velekas leadership and strategic legal counsel will be critical to Opentrons growth and expansion of product development from research to commercialization.
Technology,
Research,
Genetics,
Other Technology,
Biotechnology,
Health,
Pharmaceutical,
Other Science,
Science,
Industry,
Genomics,
NGS,
RNA transfection,
PCR,
COVID-19 testing,
Automation,
Research,
Workflow,
Molecular biology,
Magnetism,
Pyrosequencing,
Robotics,
PRL,
Solution,
COVID-19,
Drug discovery,
Opentrons,
Proteomics,
Fine chemical,
Vaccine,
Opentrons Labworks, Inc.,
Opentrons Robotics,
OPENTRONS LABWORKS, INC.,
OPENTRONS ROBOTICS The expansion of our OT-2 portfolio will bring the benefits of radically simple, accessible automation to new customers, said David Kim, general manager of Opentrons Robotics.
Key Points:
- The expansion of our OT-2 portfolio will bring the benefits of radically simple, accessible automation to new customers, said David Kim, general manager of Opentrons Robotics.
- Opentrons new workstations will bring all these benefits to scientists working across genomics and proteomics applications.
- Through our business unit, Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use lab robots.
- Opentrons Robotics, a business unit of Opentrons Labworks, Inc., is the industry leader in flexible, user-friendly automation for life science R&D labs.
